The Patent Trial and Appeal Board determined that challenged claims of EMKinetics Inc.'s patent directed to systems and/or methods for electromagnetic induction therapy are unpatentable as anticipated by and obvious over prior art, in an inter partes review by Avation Medical Inc. The board found that the challenged claims are anticipated by and obvious over various combinations of prior art, including prior art titled “Neuromodulative Treatment of Overactive Bladder — Noninvasive Tibial Nerve Stimulation,” titled “Urodynamic Effect of Acute Transcutaneous Posterior Tibial Nerve Stimulation in Overactive Bladder,” and that discloses a method and system for treatment of incontinence, urgency, frequency, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.